Amphastar Pharmaceuticals, Inc.

This study tested a new, potentially lower-cost copy (biosimilar) of a fast-acting insulin called NovoLog. The goal was to see if the new insulin behaves the same way in the body as the original. Healthy volunteers received both insulins in a carefully controlled setting to measu…